Ben Panizza

Professor Ben Panizza is a world-leading academic and clinical expert in head and neck oncology, serving as Chairman of Otolaryngology - Head and Neck Surgery for Metro South and Director of the Queensland Head and Neck Cancer Centre. He is affiliated with the Faculty of Medicine at the University of Queensland and has pioneered innovative approaches for skull base malignancies and perineural spread of keratinocyte cancers.

• Specializes in temporal bone oncology and cutaneous SCC
• Active in clinical trials from proof-of-concept to phase III
• Collaborates with industry leaders (Merck, Sanofi, QBiotics, Decibel Therapeutics)

His research spans proteomics, HPV-associated cancers, perineural invasion mechanisms, and skull base surgical techniques. Recent work focuses on AI-generated medical information quality, personalized treatment models, and novel drug delivery systems. He has supervised 28 higher degree research students and established a clinical trials unit at Princess Alexandra Hospital.

Key article trends include HPV-driven oropharyngeal cancer (proteomic signatures, immunotherapy combinations), temporal bone SCC management, and ototoxicity prevention during chemotherapy. His work frequently addresses anatomical complexity and translational research between clinical practice and basic science.